A detailed history of Choate Investment Advisors transactions in Boston Scientific Corp stock. As of the latest transaction made, Choate Investment Advisors holds 3,404 shares of BSX stock, worth $296,113. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,404
Previous 3,242 5.0%
Holding current value
$296,113
Previous $249,000 14.46%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$72.96 - $84.0 $11,819 - $13,608
162 Added 5.0%
3,404 $285,000
Q2 2024

Aug 08, 2024

SELL
$67.33 - $77.71 $1,548 - $1,787
-23 Reduced 0.7%
3,242 $249,000
Q1 2024

May 07, 2024

SELL
$57.6 - $68.62 $21,888 - $26,075
-380 Reduced 10.43%
3,265 $223,000
Q4 2023

Feb 14, 2024

SELL
$48.64 - $57.81 $14,981 - $17,805
-308 Reduced 7.79%
3,645 $210,000
Q3 2023

Oct 30, 2023

BUY
$50.19 - $54.68 $198,401 - $216,150
3,953 New
3,953 $208,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $125B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Choate Investment Advisors Portfolio

Follow Choate Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Choate Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Choate Investment Advisors with notifications on news.